Revenio Group Oyj

Revenio Group Oyj

10.92
EUR
-0.02
(-0.18%)
0.42EPS
24.05P/E
271.39MMarket Cap
Nov 12Next Earn

Latest Stock Split

Sep 22, 2026

523:438

For every 438 shares held, investors received 523. The price per share adjusted from $13.16 to $11.02.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Sep 22, 2026
    Before$13.16
    Split ratio523:438
    After$11.02
    Forward
  2. Mar 21, 2018
    Before—
    Split ratio3:1
    After—
    Forward
  3. Mar 28, 2013
    Before—
    Split ratio1:10
    After—
    Reverse
  4. May 14, 2002
    Before—
    Split ratio38:35
    After—
    Forward

About Revenio Group Oyj stock splits

Revenio Group Oyj (STU:R0V) operates in the Medical specialties industry.

Revenio Group Oyj company overview

When did Revenio Group Oyj stock split?

Revenio Group Oyj's most recent stock split was on September 22, 2026. It was a 523-for-438 forward split, so shareholders received 523 shares for every 438 they held.

What is Revenio Group Oyj's stock split history?

Revenio Group Oyj (STU:R0V) has split its stock 4 times: a 38-for-35 split on May 14, 2002, a 1-for-10 reverse split on March 28, 2013, a 3-for-1 split on March 21, 2018, and a 523-for-438 split on September 22, 2026.

How many times has Revenio Group Oyj stock split?

Revenio Group Oyj has split its stock 4 times. This history records 4 splits between May 14, 2002 and September 22, 2026.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Revenio Group Oyj's 523-for-438 split on September 22, 2026, every 438 shares became 523 shares.

Will Revenio Group Oyj split its stock again?

Revenio Group Oyj has not announced a new split in our records. Its most recent split was on September 22, 2026, less than a year ago. Companies announce splits in advance, and any new STU:R0V split will appear on this page.